Skin Disorders News

WASHINGTON — Children taking dupilumab for atopic diseases received measles, mumps and rubella and varicella immunizations later than other children, according to a poster presented here.

WASHINGTON — Urticaria treatment guidelines in the United States include more options than the World Allergy Organization’s guidelines, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

SAN DIEGO — At the American Academy of Dermatology Annual Meeting, Galderma announced new data demonstrating nemolizumab’s long-term efficacy in treating prurigo nodularis and atopic dermatitis, according to a press release.

SAN DIEGO — In children aged 2 to 5 years with atopic dermatitis, roflumilast cream 0.05% significantly improved symptoms compared with vehicle, with improvement seen as early as 1 week after treatment, according to a speaker here.

SAN DIEGO — In this video perspective, Menas Kizoulis, senior director of global scientific engagement at Kenvue, discusses the company’s latest research presented at the American Academy of Dermatology Annual Meeting.

SAN DIEGO — New data showed Vtama cream achieved consistent and strong efficacy for the treatment of atopic dermatitis across all racial groups, according to a poster presentation at the 2024 American Academy of Dermatology Annual Meeting.

Despite blood eosinophils depletion, benralizumab did not show a clinical benefit over placebo in chronic spontaneous urticaria, according to a phase 2b trial.

WASHINGTON — The most effective treatments for atopic dermatitis may also be the most harmful, according to a study presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

WASHINGTON — Patients with hereditary angioedema experienced rapid symptom relief with sebetralstat compared with placebo, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

The efficacy of tapinarof cream 1% has validated the aryl hydrocarbon receptor as a therapeutic target for the treatment of atopic dermatitis, according to a study.